Efforts Towards Polio Eradication in Madagascar: 1997 to 2017.

Certification Epidemiology Madagascar Polio eradication Polio free status Poliomyelitis

Journal

Journal of immunological sciences
Titre abrégé: J Immunol Sci
Pays: United States
ID NLM: 101721947

Informations de publication

Date de publication:
13 Apr 2021
Historique:
entrez: 17 5 2021
pubmed: 18 5 2021
medline: 18 5 2021
Statut: ppublish

Résumé

In 1988, the World Health Assembly launched the Global Polio Eradication Initiative. WHO AFRO is close to achieve this goal with the last wild poliovirus detected in 2014 in Borno States in Nigeria. The certification of the WHO African Region requires that all the 47 member states meet the critical indicators for a polio free status. Madagascar started implementing polio eradication activities in 1996 and was declared polio free in June 2018 in Abuja. This study describes the progress achieved towards polio eradication activities in Madagascar from 1977-2017 and highlights the remaining challenges to be addressed. Data were collected from the national routine immunization services, Country Acute Flaccid surveillance databases and national reports of SIAS and Mop Up campaign. Country complete polio and immunization related documentation provided detailed historical information's. From 1997 to 2017, Madagascar reported one wild poliovirus (WPV) outbreak and four circulating Vaccine Derived Polio Virus (cVDPV) oubreaks with a total of 21 polioviruses (1 WPV and 21 cVDPV). The last WPV and cVDPV were notified in 1997 in Antananarivo and 2015 in Sakaraha health districts respectively. Madagascar met the main polio surveillance indicators over the last ten years and made significant progress following the last cVDPV2 outbreak in 2014 -2015. In addition, the country successfully implemented the switch from trivalent Oral Polio Vaccine (tOPV) to bivalent Oral Polio vaccine (bOPV) and containment activities. Environmental Surveillance established since 2015 did not reveal any poliovirus. The administrative coverage of the 3rd dose of oral polio vaccine (OPV3) varied across the years from 55% in 1991 to a maximum of 95% in 2007 before a progressive decrease to 86% in 2017. The percentage of AFP cases with more than 3 doses of oral polio vaccines increased from 56% in 2014 to 88% in 2017. A total of 19 supplementary immunization activities (SIA) were conducted in Madagascar from 1997 to 2017, among which 3 were subnational immunization days (sNID) and 16 were national immunization days (NIDs). Poor routine coverage contributed to the occurrence of cVDPC outbreaks in the country; addressing this should remain a key priority for the country to maintain the polio free status.From 2015 to June 2017, Madagascar achieved the required criteria leading to the acceptance of the country's polio-free documentation in June 2018 by ARCC. However, continuous efforts will be needed to maintain a highly sensitive polio surveillance system with emphasis on security compromised areas. Finally strengthening the health system and governance at all levels will be necessary if these achievements are to be sustained. High national political commitment and support of the Global Polio Eradication Partnership were critical for Madagascar to achieve polio free status. Socio-political instability, weakness of the health system, sub-optimal routine immunization performance, insufficient SIA quality and existing security compromised areas remain critical program challenges to address in order to maintaining the polio free status. Continuous high-level advocacy should be kept in order to ensure that new government authorities maintain polio eradication among the top priorities of the country.

Sections du résumé

BACKGROUND BACKGROUND
In 1988, the World Health Assembly launched the Global Polio Eradication Initiative. WHO AFRO is close to achieve this goal with the last wild poliovirus detected in 2014 in Borno States in Nigeria. The certification of the WHO African Region requires that all the 47 member states meet the critical indicators for a polio free status. Madagascar started implementing polio eradication activities in 1996 and was declared polio free in June 2018 in Abuja. This study describes the progress achieved towards polio eradication activities in Madagascar from 1977-2017 and highlights the remaining challenges to be addressed.
METHODS METHODS
Data were collected from the national routine immunization services, Country Acute Flaccid surveillance databases and national reports of SIAS and Mop Up campaign. Country complete polio and immunization related documentation provided detailed historical information's.
RESULTS RESULTS
From 1997 to 2017, Madagascar reported one wild poliovirus (WPV) outbreak and four circulating Vaccine Derived Polio Virus (cVDPV) oubreaks with a total of 21 polioviruses (1 WPV and 21 cVDPV). The last WPV and cVDPV were notified in 1997 in Antananarivo and 2015 in Sakaraha health districts respectively. Madagascar met the main polio surveillance indicators over the last ten years and made significant progress following the last cVDPV2 outbreak in 2014 -2015. In addition, the country successfully implemented the switch from trivalent Oral Polio Vaccine (tOPV) to bivalent Oral Polio vaccine (bOPV) and containment activities. Environmental Surveillance established since 2015 did not reveal any poliovirus. The administrative coverage of the 3rd dose of oral polio vaccine (OPV3) varied across the years from 55% in 1991 to a maximum of 95% in 2007 before a progressive decrease to 86% in 2017. The percentage of AFP cases with more than 3 doses of oral polio vaccines increased from 56% in 2014 to 88% in 2017. A total of 19 supplementary immunization activities (SIA) were conducted in Madagascar from 1997 to 2017, among which 3 were subnational immunization days (sNID) and 16 were national immunization days (NIDs). Poor routine coverage contributed to the occurrence of cVDPC outbreaks in the country; addressing this should remain a key priority for the country to maintain the polio free status.From 2015 to June 2017, Madagascar achieved the required criteria leading to the acceptance of the country's polio-free documentation in June 2018 by ARCC. However, continuous efforts will be needed to maintain a highly sensitive polio surveillance system with emphasis on security compromised areas. Finally strengthening the health system and governance at all levels will be necessary if these achievements are to be sustained.
CONCLUSIONS CONCLUSIONS
High national political commitment and support of the Global Polio Eradication Partnership were critical for Madagascar to achieve polio free status. Socio-political instability, weakness of the health system, sub-optimal routine immunization performance, insufficient SIA quality and existing security compromised areas remain critical program challenges to address in order to maintaining the polio free status. Continuous high-level advocacy should be kept in order to ensure that new government authorities maintain polio eradication among the top priorities of the country.

Identifiants

pubmed: 33997860
doi: 10.29245/2578-3009/2021/S2.1102
pmc: PMC7610765
mid: EMS123271
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1102

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Références

MMWR Morb Mortal Wkly Rep. 2017 Aug 18;66(32):854-858
pubmed: 28817551
MMWR Morb Mortal Wkly Rep. 2018 Mar 02;67(8):253-256
pubmed: 29494568
MMWR Morb Mortal Wkly Rep. 2017 Nov 24;66(46):1276-1280
pubmed: 29166363
MMWR Morb Mortal Wkly Rep. 2018 May 11;67(18):524-528
pubmed: 29746452
Trop Med Int Health. 2001 Dec;6(12):1032-9
pubmed: 11737841

Auteurs

Marcellin Mengouo Nimpa (MM)

World Health Organization Regional Office for Africa, Congo.

Noёline Ravelomanana Razafiarivao (NR)

Faculté de Médécine d'Anatanarivo, Madagascar.

Annick Robinson (A)

Centre Hospitalier Universitaire Mère Enfant Tsaralalana (CHUMET) -Antananarivo.

Mamy Randriatsarafara Fidiniaina (MR)

Direction Centrale du Service Militaire d'Antanarivo.

Richter Razafindratsimandresy (R)

Institut Pasteur de Madagascar.

Yolande Vuo Masembe (YV)

World Health Organization Regional Office for Africa, Congo.

Christiane Ramonjisoa Bodohanta (CR)

Expanded Programme of Immunization, Madagascar.

Isidore Koffi Kouadio (IK)

World Health Organization Regional Office for Africa, Congo.

Issa Kana Kode Nyazy (IKK)

World Health Organization Regional Office for Africa, Congo.

Moussa Simpore (M)

World Health Organization Regional Office for Africa, Congo.

Charlotte Faty Ndiaye (CF)

World Health Organization Regional Office for Africa, Congo.

Joseph Chukwudi Okeibunor (JC)

World Health Organization Regional Office for Africa, Congo.

Classifications MeSH